Posts tagged drug products

• Zimulti And Suicidal Thoughts...A Link Has Been Shown According To Reports

  M. Brandon Smith | June 12, 2007 12:03 AM | 0 CommentsAtlanta, GA Category: FDA & Prescription Drugs
  

  According to recent reports, Zimulti, an obesity drug manufactured by Sanofi-Aventis SA has been linked to an increase in suicidal thoughts in its consumers. Although the drug is not currently being sold in the U.S, an FDA advisory panel is set to discuss Zimulti Wednesday to consider whether its approval should be granted in the states. Known generically as rimonabant, the drug already is sold...

• Avandia And GlaxoSmithKline-More Controversy And Reported Threats To Patient Oriented Doctor

  M. Brandon Smith | June 06, 2007 5:36 PM | 0 CommentsAtlanta, GA Category: Defective & Dangerous Products
  

  Issues surrounding GlaxoSmithKline's controversial diabetes drug Avandia continued today in a recent article published by ABCNEWS: Doctor to Testify in Avandia Hearing on Hill. According to reports, Dr. John Buse was contacted by SmithKline Beecham in 1999 after noting an increased trend of heart related problems in patients that were taking Avandia. Dr. Buse was reportedly threatened by the...

• Revised Black Box Warning For KETEK (Telithromycin)

  M. Brandon Smith | April 01, 2007 9:20 AM | 0 CommentsAtlanta, GA Category: FDA & Prescription Drugs
  

  KETEK (telithromycin), manufactured and sold by Sanofi-aventis U.S. recently decided, after prompting by the U.S. Food and Drug Administration, to include a revised black box warning and contraindication for myasthenia gravis patients. The new warning also removed the labels recommendation that KETEK be used in patients with chronic bronchitis (AECB) and acute bacterial sinusitis (ABS). For more...

• Voluntary Recall Of Zelnorm Issued After Prompt By FDA

  M. Brandon Smith | March 31, 2007 11:02 PM | 4 CommentsAtlanta, GA Category: Defective & Dangerous Products
  

  The sale of Zelnorm, (tegaserod maleate) approved in 2002 for treatment of irritable bowel syndrome with constipation, has recently been suspended by its manufacturer, Novartis, after the drug has been linked to a significant number of cardiovascular risks. This decision was made after the United State Food and Drug Administration found the drug can lead to increased occurrences of heart attack,...

• Nationwide Recall Of Permax (Pergolide) Issued

  M. Brandon Smith | March 30, 2007 2:48 PM | 0 CommentsAtlanta, GA Category: FDA & Prescription Drugs
  

  The United States Food and Drug Administration has issued a public health announcement concerning the withdrawal of Permax (Pergolide) from the market due to a link of increased heart valve damage in its consumers. The advisory indicates two new studies showed patient's with Parkinson' Disease, who ingested pergolide, were at a higher risk of developing cardiovascular problems than those who did...

• Defense Verdict In Madison County Vioxx Trial

  M. Brandon Smith | March 27, 2007 9:57 PM | 1 CommentAtlanta, GA Category: Defective & Dangerous Products
  

  In the latest Vioxx trial, a Madison County jury found in favor of Merck & Co. after deliberating for more than 6 hours over the course of two days. The jury members rejected Patty Schwaller widower's claim that Merck & Co. was to blame for his wife's sudden death linked to cardiovascular side effects. In siding with Merck, the jury concluded that Vioxx was not a "proximate cause" in the death...

• Will RotaTeq Be Linked To New Intussusception Cases?

  M. Brandon Smith | March 24, 2007 1:23 AM | 0 CommentsAtlanta, GA Category: Defective & Dangerous Products
  

  RotaTeq, a vaccine manufactured by Merck & Co., that received FDA approval in February of 2006, is currently being investigated for a connection to a condition called intussusception. Intussusception is a very serious and life threatening condition that causes the intestines to twist and form blockages. It is a fairly rare condition, but more than 28 cases have been reported lately in various...

• Plaintiff's Finish Their Case In Midwest Vioxx Trial

  M. Brandon Smith | March 18, 2007 4:20 PM | 0 CommentsAtlanta, GA Category: FDA & Prescription Drugs
  

  The Plaintiff's side of the case has been concluded in Madison County where the family of Patricia Schwaller has alleged that Vioxx contributed to and caused the 52-year-olds death. It was shown in the Plaintiff's case in chief that Schwaller, who died in 2003, did not have a history of heart attacks, strokes or other symptoms of congestive heart disease prior to her use of Merck & Co.'s Vioxx....

• Sleeping Aids Maybe More Dangerous Than Originally Thought

  M. Brandon Smith | March 17, 2007 10:52 AM | 0 CommentsAtlanta, GA Category: Defective & Dangerous Products
  

  If you currently take Ambien,Butisol Sodium, Carbrital, Dalmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem, Seconal, and/or Sonata you ought to be aware of a recent concern issued by the U.S. Food and Drug Administration relating to their use in connection with some very serious side effects. The drugs listed above are commonly prescribed to millions of consumers to address...

• $47.5 Million Vioxx Verdict After Idaho Man Suffers Heart Attack

  M. Brandon Smith | March 12, 2007 6:24 PM | 0 CommentsAtlanta, GA Category: FDA & Prescription Drugs
  

  An Atlantic City jury returned a plaintiff's verdict today against Merck & Co. to the tune of $47.5 million after its arthritis drug Vioxx lead to an Idaho postal worker's heart attack. $20 of the $47.5 million was awarded for compensatory damages and the remaining $27.5 million was awarded as punitive damages in order to punish Merck & Co. for their failure to warn about the cardiovascular...